Patient Reported Outcomes In Triple Class Exposed, Relapsed/Refractory Multiple Myeloma (Tce Rrmm) Patients In Karmma 3 Trial (Phase 3 Rct): Idecabtagene Vicleucel (Ide-Cel) Versus Standard Regimens
Idecabtagene Vicleucel
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Patient Reported Outcomes In Triple Class Exposed, Relapsed/Refractory Multiple Myeloma (Tce Rrmm) Patients In Karmma 3 Trial (Phase 3 Rct): Idecabtagene Vicleucel (Ide-Cel) Versus Standard Regimens ### Output: Idecabtagene Vicleucel